GE announced the formation of a new equity fund, the $250 million GE Healthymagination Fund, which will make investments in healthcare technology companies.
The fund will invest in companies globally that have diagnostic, IT and life sciences technologies aligned with GE’s Healthymagination initiative. The fund will also support healthcare companies developing “innovative and unique business models and services.”
The company said the fund’s formation is part of its $6 billion Healthymagination initiative. The fund will target three areas for investment:
- Broad-based diagnostics, including imaging, home health, patient monitoring, molecular diagnostics, pathology, imaging agents and other technologies for disease diagnosis.
- Healthcare IT, including EMRs, clinical information systems, healthcare information exchanges and value-added data services.
- Life Sciences, including tools for R &D in biopharmaceuticals and stem cells, and technologies for the manufacturing of biopharmaceuticals and vaccines.
GE said the fund will draw on capabilities from across GE Healthcare, GE Capital and GE Global Research.